CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy

por Barlési, F, Tchouhadjian, C, Doddoli, C, Torre, J-P, Astoul, P, Kleisbauer, J-P
Publicado 2005

High dose etoposide for brain metastases of small cell lung cancer. A phase II study. The EORTC Lung Cancer Cooperative Group.

por Postmus, P. E., Haaxma-Reiche, H., Sleijfer, D. T., Kirkpatrick, A., McVie, J. G., Kleisbauer, J. P.
Publicado 1989